Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events

BACKGROUND: Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. Much debate has surrounded possible causal links for this association and whether regular (daily) long-acting beta2-agonists are safe when used alone or in conjunction with inhaled corticosteroids. This is an updated Cochrane Review. OBJECTIVES: To assess the risk of fatal and non-fatal serious adverse events in people with …